Xiaojiang Li

机构：Jinan University, Dalian Medical University, Kunming Medical University, Kunming Third People's Hospital, Second Affiliated Hospital of Dalian Medical University, ShenZhen People’s Hospital

发表论文 140 篇 · 总被引 3162 次 · h-index 27

代表论文

• Finotonlimab with chemotherapy in recurrent or metastatic head and neck cancer: a randomized phase 3 trial (2024 · Nature Medicine · 被引 32)
• Mechanisms of cancer cell death induction by triptolide: A comprehensive overview (2024 · Heliyon · 被引 29)
• Neuroinflammatory Proteins in Huntington’s Disease: Insights into Mechanisms, Diagnosis, and Therapeutic Implications (2024 · International Journal of Molecular Sciences · 被引 25)
• Carboxymethyl cellulose-based supramolecular hydrogel with thermo-responsive gel-sol transition for temporary plugging of oil pipeline in hot work (2023 · Carbohydrate Polymers · 被引 22)
• Suppressing UBE2N ameliorates Alzheimer's disease pathology through the clearance of amyloid beta (2024 · Alzheimer s & Dementia · 被引 20)
• Multiple-Stimuli-Responsive Surfactant-Free Microemulsions Based on Hydrophobic Deep Eutectic Solvents (2023 · Langmuir · 被引 19)